Advancing Subcutaneous Dosing Regimens for Biotherapeutics: Clinical Strategies for Expedited Market Access
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine,Biotechnology
Link
https://link.springer.com/content/pdf/10.1007/s40259-023-00626-1.pdf
Reference120 articles.
1. Bittner B, Richter W, Schmidt J. Subcutaneous administration of biotherapeutics: an overview of current challenges and opportunities. BioDrugs. 2018;32(5):425–40. https://doi.org/10.1007/s40259-018-0295-0.
2. McCreary EK, Bariola JR, Wadas RJ, Shovel JA, Wisniewski MK, Adam M, et al. Association of subcutaneous or intravenous administration of casirivimab and imdevimab monoclonal antibodies with clinical outcomes in adults with COVID-19. JAMA Netw Open. 2022;5(4): e226920. https://doi.org/10.1001/jamanetworkopen.2022.6920.
3. Bittner B. Drug delivery improvements to enable a flexible care setting for monoclonal antibody medications in oncology—analogue-based decision framework. Expert Opin Drug Deliv. 2023;20(4):457–70. https://doi.org/10.1080/17425247.2023.2184343.
4. Wynendaele E, Furman C, Wielgomas B, Larsson P, Hak E, Block T, et al. Sustainability in drug discovery. Med Drug Discov. 2021;12: 100107. https://doi.org/10.1016/j.medidd.2021.100107.
5. The Electronic Medicines Compendium. 2023. Available at: https://www.medicines.org.uk/emc/about-the-emc#gref. (Accessed 15 Jun 2023).
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Reversible protein complexes: Advancing subcutaneous delivery with controlled and sustained release of high concentration biologics;Journal of Drug Delivery Science and Technology;2024-10
2. Patients with multiple sclerosis who develop immunogenicity to interferon-beta have distinct transcriptomic and proteomic signatures prior to treatment which are associated with disease severity;Clinical Immunology;2024-10
3. Stick With Intravenous or Give Subcutaneous a Shot? Time and Other Considerations When Evaluating Cancer Drug Formulations;JCO Oncology Practice;2024-08-02
4. Recent Developments in Convenience of Administration of the Anti-CD38 Antibody Isatuximab: Subcutaneous Delivery and Fast Intravenous Infusion in Patients With Multiple Myeloma;Clinical Lymphoma Myeloma and Leukemia;2024-06
5. Subcutaneous delivery of immune checkpoint inhibitors: new route replacing intravenous administration?;Translational Lung Cancer Research;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3